Fmr LLC Neuro Pace Inc Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Fmr LLC holds 249,394 shares of NPCE stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

249,394

Previous 302,803 17.64%

Holding current value

$1.57 Million

Previous $4 Million 52.83%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$6.38 - $15.33 $340,749 - $818,759	-53,409 Reduced 17.64%	249,394 $1.89 Million
Q1 2024 May 13, 2024	SELL	$9.78 - $17.5 $1.62 Million - $2.89 Million	-165,278 Reduced 35.31%	302,803 $4 Million
Q4 2023 Feb 13, 2024	SELL	$5.9 - $10.31 $1.41 Million - $2.46 Million	-238,164 Reduced 33.72%	468,081 $4.83 Million
Q3 2023 Nov 13, 2023	SELL	$4.0 - $9.73 $2.07 Million - $5.03 Million	-517,418 Reduced 42.28%	706,245 $6.87 Million
Q2 2023 Aug 11, 2023	SELL	$3.98 - $5.12 $1.07 Million - $1.38 Million	-269,268 Reduced 18.04%	1,223,663 $5.49 Million
Q1 2023 May 11, 2023	BUY	$1.44 - $5.34 $61,927 - $229,646	43,005 Added 2.97%	1,492,931 $6.93 Million
Q3 2022 Nov 10, 2022	BUY	$3.1 - $5.98 $96,022 - $185,230	30,975 Added 2.18%	1,449,926 $5.44 Million
Q2 2022 Aug 12, 2022	BUY	$4.95 - $8.7 $57,642 - $101,311	11,645 Added 0.83%	1,418,951 $7.02 Million
Q1 2022 May 13, 2022	BUY	$7.06 - $11.57 $2.41 Million - $3.95 Million	341,269 Added 32.01%	1,407,306 $11.6 Million
Q4 2021 Feb 14, 2022	BUY	$8.63 - $17.36 $5,626 - $11,318	652 Added 0.06%	1,066,037 $10.7 Million
Q3 2021 Nov 15, 2021	BUY	$15.85 - $25.07 $84,417 - $133,522	5,326 Added 0.5%	1,065,385 $16.9 Million
Q2 2021 Aug 13, 2021	BUY	$19.03 - $26.5 $20.2 Million - $28.1 Million	1,060,059 New	1,060,059 $25.2 Million

Others Institutions Holding NPCE

# of Institutions

Shares Held

19.8M

Call Options Held

28.3K

Put Options Held

300

View Full List

About NeuroPace Inc

Ticker NPCE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,846,900
Market Cap $156M
Description
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...

More about NPCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account